Robert Peter Budetti
Director Ejecutivo en Feighner Research Institute .
Perfil
Robert Peter Budetti is the founder of the Institute for Creation Research, which was founded in 1984.
He held the title of Chief Financial & Operating Officer from 1984 to 1992.
Mr. Budetti is currently the Chief Executive Officer at Feighner Research Institute since 1979 and the Chief Operating Officer & Director at Tetragenex Pharmaceuticals, Inc. since 1999.
He previously worked as the Chief Financial Officer-ICR Division at Quintiles, Inc. (California) from 1992 to 1994.
Mr. Budetti received his undergraduate degree from Harvard University in 1963 and his MBA in 1968.
Cargos activos de Robert Peter Budetti
| Empresas | Cargo | Inicio |
|---|---|---|
Tetragenex Pharmaceuticals, Inc.
 Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Director de Operaciones | 05/02/2010 |
| Feighner Research Institute | Director Ejecutivo | 05/02/2010 |
Antiguos cargos conocidos de Robert Peter Budetti.
| Empresas | Cargo | Fin |
|---|---|---|
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 02/01/1994 |
| Institute for Creation Research | Fundador | 02/01/1992 |
Formación de Robert Peter Budetti.
| Harvard University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Tetragenex Pharmaceuticals, Inc.
Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY. | Health Technology |
| Feighner Research Institute | |
| Institute for Creation Research | |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
- Bolsa de valores
- Insiders
- Robert Peter Budetti
